Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Health Catalyst (HCAT) Cash from Financing Activities (2018 - 2025)

Health Catalyst (HCAT) has disclosed Cash from Financing Activities for 8 consecutive years, with -$537000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Cash from Financing Activities fell 100.48% year-over-year to -$537000.0, compared with a TTM value of -$197.7 million through Sep 2025, down 272.7%, and an annual FY2024 reading of $151.7 million, up 5458.46% over the prior year.
  • Cash from Financing Activities was -$537000.0 for Q3 2025 at Health Catalyst, up from -$230.1 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $248.8 million in Q3 2021 and bottomed at -$230.1 million in Q2 2025.
  • Average Cash from Financing Activities over 5 years is $9.5 million, with a median of $1.0 million recorded in 2023.
  • The sharpest move saw Cash from Financing Activities surged 10716.83% in 2024, then crashed 33065.47% in 2025.
  • Year by year, Cash from Financing Activities stood at $3.9 million in 2021, then plummeted by 83.73% to $637000.0 in 2022, then crashed by 37.99% to $395000.0 in 2023, then skyrocketed by 9441.77% to $37.7 million in 2024, then crashed by 101.42% to -$537000.0 in 2025.
  • Business Quant data shows Cash from Financing Activities for HCAT at -$537000.0 in Q3 2025, -$230.1 million in Q2 2025, and -$4.7 million in Q1 2025.